Katie is a member of the Life Sciences Health Industry Group in the Washington, D.C. office. She represents a variety of health care providers, suppliers, manufacturers, associations, and others regarding regulatory issues arising under the Medicare and Medicaid programs and under the health care fraud and abuse laws, including anti-kickback, physician self-referral, beneficiary inducement, and false claims laws.
Qualifikationen
Notable Quotes
- 26 January 2017 "Drug, Device Company Payments to Doctors Top $7 Billion" Bloomberg BNA's Health Care Fraud Report